These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19432906

  • 1. Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer.
    Onuki M, Matsumoto K, Satoh T, Oki A, Okada S, Minaguchi T, Ochi H, Nakao S, Someya K, Yamada N, Hamada H, Yoshikawa H.
    Cancer Sci; 2009 Jul; 100(7):1312-6. PubMed ID: 19432906
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
    Onuki M, Matsumoto K, Iwata T, Yamamoto K, Aoki Y, Maenohara S, Tsuda N, Kamiura S, Takehara K, Horie K, Tasaka N, Yahata H, Takei Y, Aoki Y, Kato H, Motohara T, Nakamura K, Ishikawa M, Kato T, Yoshida H, Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yaegashi N, Yoshikawa H.
    Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX, Du H, Liu ZH, Zhang LJ, Wang C, Wu RF.
    Zhonghua Zhong Liu Za Zhi; 2018 Mar 23; 40(3):232-238. PubMed ID: 29575846
    [Abstract] [Full Text] [Related]

  • 4. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C.
    Cancer Cytopathol; 2022 Jul 23; 130(7):542-550. PubMed ID: 35312217
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
    Zhang J, Cheng K, Wang Z.
    Arch Gynecol Obstet; 2020 Dec 23; 302(6):1329-1337. PubMed ID: 32914222
    [Abstract] [Full Text] [Related]

  • 6. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    BMC Cancer; 2022 Jan 06; 22(1):42. PubMed ID: 34991494
    [Abstract] [Full Text] [Related]

  • 7. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.
    Health Technol Assess; 2014 Apr 06; 18(23):1-196. PubMed ID: 24762804
    [Abstract] [Full Text] [Related]

  • 8. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.
    J Med Virol; 2011 Jun 06; 83(6):1034-41. PubMed ID: 21503917
    [Abstract] [Full Text] [Related]

  • 9. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
    Zhang J, Zhang D, Yang Z, Wang X, Wang D.
    BMC Cancer; 2020 May 19; 20(1):443. PubMed ID: 32429919
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
    Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.
    J Natl Cancer Inst; 2009 Apr 01; 101(7):475-87. PubMed ID: 19318628
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
    Saeki Y, Saito M, Irie T, Itoh F, Enatsu A, Komura H, Fujii M, Fujii R, Hidaka N, Maehama T, Shirasu N, Waseda T, Shibata T, Takada E, Mibe K, Sakamoto J, Yamada S, Takakura M, Sasagawa T.
    J Med Virol; 2024 Feb 01; 96(2):e29413. PubMed ID: 38314927
    [Abstract] [Full Text] [Related]

  • 12. The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
    Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Robertson M, Castle PE, New Mexico HPV Pap Registry Steering Committee.
    Int J Cancer; 2014 Aug 01; 135(3):624-34. PubMed ID: 24226935
    [Abstract] [Full Text] [Related]

  • 13. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Bukowski A, Hoyo C, Hudgens MG, Brewster WR, Valea F, Bentley RC, Vidal AC, Maguire RL, Schmitt JW, Murphy SK, North KE, Smith JS.
    Cancer Epidemiol Biomarkers Prev; 2022 Aug 02; 31(8):1564-1571. PubMed ID: 35654413
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.
    Cancer Epidemiol; 2012 Oct 02; 36(5):e284-7. PubMed ID: 22608058
    [Abstract] [Full Text] [Related]

  • 15. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL.
    Lancet Oncol; 2018 Dec 02; 19(12):1569-1578. PubMed ID: 30392810
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.
    Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X.
    BMC Infect Dis; 2017 Jan 31; 17(1):107. PubMed ID: 28143439
    [Abstract] [Full Text] [Related]

  • 17. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
    Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O'Leary J, Joura EA, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De Souza SC, Jenkins D, Holl K, HERACLES/SCALE Study Group.
    Int J Cancer; 2013 Feb 15; 132(4):854-67. PubMed ID: 22752992
    [Abstract] [Full Text] [Related]

  • 18. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
    Zhao XL, Hu SY, Zhang Q, Dong L, Feng RM, Han R, Zhao FH.
    J Gynecol Oncol; 2017 Jul 15; 28(4):e30. PubMed ID: 28541628
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
    Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM.
    Int J Cancer; 2012 Nov 15; 131(10):2349-59. PubMed ID: 22323075
    [Abstract] [Full Text] [Related]

  • 20. Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand.
    Kang YJ, Lewis H, Smith MA, Simonella L, Neal H, Bromhead C, Canfell K.
    BMC Infect Dis; 2015 Aug 22; 15():365. PubMed ID: 26297490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.